This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
Liver transplantation is a necessity for many chronic liver diseases, including hepatocellular carcinoma, chronic hepatitis C, and alcoholic liver disease. Over the past year, researchers and physicians have reported changes among the leading indications on the liver waitlist and improvements in transplantation outcomes.
In this article, Healio.com/Hepatology presents recent reports on waitlist mortality risks, improved pediatric liver transplantation outcomes, and the positive effects of HCV treatment on transplant and waitlist outcomes.
The topics are:
- HCC liver transplant outcomes better in children with inherited liver disease
- Low skeletal muscle mass increases risk for liver waitlist mortality
- HCV nucleic acid test offers ‘opportunity’ to increase liver transplant pool
- Alcoholic liver disease overtakes HCV as leading indication on liver waitlist
- Expanding liver transplant criteria offers comparable survival
- Liver tumor program launched to ‘work in a fashion of teamwork’
- Liver waitlist outcomes for patients with HCV improving in recent years